Pediatrics Unit Intravenous Push (IVP) Drug List - Approved for RN ...
[Pages:9]Generic Name (Brand Names) Adenosine
Amiodarone
Ampicillin
Atropine Sulfate Calcium Chloride
Pediatrics Unit Intravenous Push (IVP) Drug List - Approved for RN Administration
Ventura County Medical Center
Therapeutic Category Antiarrhythmic
Antiarrhythmic (Class III)
Antibiotic Beta-Lactam (Penicillin)
Anticholinergic Agent Electrolyte HIGH ALERT
Typical Pediatric Dose Maximum Pediatric Dose
0.1 mg/kg (max: 6 mg) Max single dose:
Second dose:
12 mg
0.2 mg/kg (max: 12 mg)
5 mg/kg May repeat dose up to 15 mg/kg/DAY.
Max single dose: 300 mg Max daily dose: 15 mg/kg/DAY
100-200 mg/kg/DAY divided every 6 hours
0.02 mg/kg/dose. May repeat once. Minimum dose = 0.1 mg. 10-20 mg/kg* *dose expressed in mg of calcium chloride
Max single dose: 2000 mg Max daily dose: 400 mg/kg/DAY, up to 12 GM/day for meningitis Max single dose: 0.5 mg
Max single dose: 1000 mg
Maximum Concentration Give undiluted (3 mg/mL)
Dilute in D5W only. PIV: 2 mg/mL Central: 6 mg/mL
Neonates/infants: 50 mg/mL Pediatrics: 100 mg/mL
Maximum rate of Administration Adverse Effects/
Administration Considerations Monitoring
Parameters
Rapid IVP over 2- EMERGENCY Monitor for transient
3 seconds.
USE ONLY.
bradycardia, asystole,
Follow dose with and ventricular
rapid 5-10 mL NS arrhythmias.
flush.
PSVT may re-occur.
Monitor EKG, HR, BP
Give over 10 mins. IV PUSH FOR
& RR. HR, BP, EKG.
For perfusing
EMERGENCY For long-term therapy,
tachycardias, give USE ONLY.
consider monitoring
over 20-60 mins. Carefully monitor chest X-ray and lung
for rate-related function.
hypotension.
Black Box Warning:
pulmonary toxicity,
hepatotoxicity, and
proarrhythmic effects. IVP over 3-5 mins. Do not administer Contraindicated in
with gentamicin in patients with a history of
the same tubing or penicillin allergy.
administer
concurrently.
May give undiluted IVP over 1-2
Doses < 0.1 mg Monitor VS & EKG.
(0.1 mg/mL)
minutes.
may cause
Minor side effects: Dry
paradoxical
mouth, dizziness &
bradycardia.
palpitations.
For IV push, may IVP over 3-5
IV PUSH FOR Bradycardia, cardiac
give undiluted minutes.
EMERGENCY arrhythmias, lethargy,
(100 mg/mL). IV infusion over 1 USE ONLY.
EEG. Stop infusion if
For IV infusion, hour
Do not use scalp patient complains of
dilute to 20
vein or small hand pain at injection site.
mg/mL.
or foot vein.
Do NOT give IM
or SQ.
Page 1 of 9
MEC Approved: 10/9/2012
Pediatrics Unit Intravenous Push (IVP) Drug List - Approved for RN Administration
Ventura County Medical Center
Generic Name (Brand Names) Calcium Gluconate
Cefazolin (Ancef, Kefzol) CefoTAXime
CefTAZidime
CefTRIAXone (Rocephin)
Therapeutic Category Electrolyte
HIGH ALERT
Antibiotic (Cephalosporin, 1st Generation) Antibiotic (Cephalosporin, 3rd Generation)
Antibiotic (Cephalosporin, 3rd Generation) Antibiotic (Cephalosporin, 3rd Generation)
Typical Pediatric Dose Maximum Pediatric Dose
50-100 mg/kg/dose* *dose expressed in mg of calcium gluconate
Max daily dose: 500 mg/kg/DAY
25-100 mg/kg/DAY Max daily dose:
divided every 6-8 hours. 100 mg/kg/DAY,
up to 6 gm/day in
children.
50 mg/kg/dose every 8 Max single dose:
hours
2000 mg
Meningitis: 75
mg/kg/dose every 6
hours
50 mg/kg/dose every 8 Max single dose:
hours
2000 mg
50-75 mg/kg/DAY divided every 12-24 hours Meningitis: 50 mg/kg/dose every 12 hours
Max single dose: 2000 mg
Maximum Concentration
For IV push, may give undiluted (100 mg/mL). For IV infusion, dilute to 50 mg/mL.
100 mg/mL For IV infusion, dilute to 20 mg/mL. 60 mg/mL
180 mg/mL. For IV infusion, dilute to 40 mg/mL. 40 mg/mL
Maximum rate of Administration Adverse Effects/
Administration Considerations Monitoring
Parameters
IVP over 3-5 min, IV PUSH FOR Bradycardia, cardiac
not to exceed 50- EMERGENCY arrhythmias, lethargy,
100 mg/per min. USE ONLY.
EEG. Stop infusion if
IV infusion over 1 Do not use scalp patient complains of
hour.
vein or small hand pain at injection site.
or foot vein.
Do NOT give IM
IVP over 3-5
or SQ. None
Caution in patients with
minutes.
a history of penicillin
IV infusion over
allergy.
10-60 minutes.
IVP over 5
Fast IVP (5
mcg/kg, slow IVP
over 5-10 minutes.
Adverse Effects/ Monitoring Parameters Headaches, dizziness.
RR, BP, HR, bowel sounds.
Antidote: GABA receptor antagonist
Loop Diuretic
0.01 mg/kg (max: 0.2 Max single dose: May give undiluted Infuse over 15 to
mg); may repeat dose 0.2 mg
(0.1 mg/mL)
30 seconds via a
every minute up to
Max total dose:
freely running IV
maximum of 0.05 mg/kg 1 mg
infusion into a
or 1 mg total 0.5-1 mg/kg/dose every Do not exceed
large vein. May give undiluted IVP over 1-2
6-12 hours
10mg/kg total for a (10 mg/mL)
minutes.
24-hour period.
EMERGENCY Black Box Warning:
USE ONLY.
administration has been
Do not exceed 0.2 associated with
mg/min.
seizures.
Rapid & high dose Contraindicated in
administration can sulfonamide allergy.
cause irreversible Hypotension, headache
hearing loss.
& dizziness. Monitor for
hearing loss.
Black Box Warning:
may cause profound
diuresis and
water/electrolyte
depletion.
Anticholinergic Agent
Control of secretions: Max single dose:
4-10 mcg/kg every 6-8 100 mcg
hours.
(May exceed max
Neuromuscular blockade single dose when
reversal:
used with
0.2 mg for every 1mg neostigmine
neostigmine used
reversal).
May give undiluted IVP over 1-2
(0.2 mg/mL)
minutes.
Dysrhythmias have Blurred vision, dry been reported with mouth, N/V, urinary administration. hesitancy & retention.
Page 4 of 9
MEC Approved: 10/9/2012
Pediatrics Unit Intravenous Push (IVP) Drug List - Approved for RN Administration
Ventura County Medical Center
Generic Name (Brand Names) Haloperidol Lactate (Haldol)
HydrALAZINE
Therapeutic Category
Antipsychotic
Typical Pediatric Dose Maximum Pediatric Dose
0.01-0.2 mg/kg/dose
0.1 mg/kg/dose, not to exceed 5 mg.
Maximum Concentration
Maximum rate of Administration Administration Considerations
May give undiluted Slow IVP (5 mg/mL)
Do NOT inject haloperidol decanoate. QT-prolongation and torsades de pointes have been reported with IV administration.
Adverse Effects/ Monitoring Parameters Hypotension, extrapyramidal symptoms, dystonic reactions, QTprolongation, torsades de pointes. ECG should be monitored. Black Box Warning: increased risk of death in elderly patients with dementia
Antihypertensive: 0.1-0.2 mg/kg/dose
Vasodilator
every 4-6 hours
Max single dose: 20 mg
May give undiluted IVP over 1-2
(20 mg/mL)
minutes, not to
exceed 0.2
mg/kg/minute.
May cause reflex tachycardia.
Palpitations, flushing, tachycardia, hypotension, arthralgias. Monitor heart rate, BP.
Hydrocortisone Succinate (Solu-Cortef)
Hydromorphone (Dilaudid)
Anti-inflammatory 1-5 mg/kg/DAY every 6- None
Agent:
8 hours
Corticosteroid
Opioid analgesic HIGH ALERT
Initial dose: 5-15 mcg/kg/dose
None
50 mg/mL
IVP over 30 seconds
May give undiluted IVP over 2-3
(2 mg/mL)
minutes
Medication is
Hypertension,
usually placed hyperglycemia,
inline, but may be insomnia, nervousness
pushed.
Reversal agent ? Respiratory rate,
naloxone (Narcan) hypotension.
Black Box Warning:
risk of respiratory
depression, drug
interactions with other
CNS depressants, abuse
and medication errors.
Page 5 of 9
MEC Approved: 10/9/2012
Generic Name (Brand Names) Insulin
Ketoralac (Toradol)
Levothyroxine (Synthroid) Lidocaine
Pediatrics Unit Intravenous Push (IVP) Drug List - Approved for RN Administration
Ventura County Medical Center
Therapeutic Category
Insulin
HIGH ALERT
Typical Pediatric Dose Maximum Pediatric Dose
0.1 unit/kg
N/A
Maximum Concentration
100 units/mL
Maximum rate of Administration Administration Considerations
For life-threatening FOR
hyperkalemia: EMERGENCY
give over 10
USE ONLY.
seconds after
Use only regular
dextrose 25%. insulin for IV
For non-life-
administration
threatening
hyperkalemia:
Give over 15-30
minutes with
dextrose 25%.
Adverse Effects/ Monitoring Parameters Monitor blood sugars, signs/symptoms of hypoglycemia
Non-steroidal anti- Loading dose:
Age 16 years &
0.5 mg/kg/dose every 6- >50 kg:
8 hours
30 mg
30 mg/mL
Give over >15 seconds.
Requires dose Edema, drowsiness,
adjustment in renal renal toxicity.
dysfunction.
Contraindicated in pts
with active or recent
bleeds, or taking aspirin
or other NSAIDs.
Black Box Warning:
Increased risk of
bleeding,
nephrotoxicity, and
cardiovascular
thrombotic events.
Thyroid Product 2-8 mcg/kg/dose Antiarrhythmic 1 mg/kg
Not established.
Max single dose: 100 mg/dose Max cumulative dose: 5 mg/kg
100 mcg/mL; dilute in NS only
20 mg/mL
Give over 2-3 Use immediately Palpitations,
minutes.
after
tachycardia, cardiac
reconstitution. arrhythmias,
nervousness, tremor.
IVP over 5-10 min, EMERGENCY Contraindicated in
not to exceed 0.7 USE ONLY.
patients with severe
mg/kg/min or 50 Can be given via heart block.
mg/min.
ETT at 2-2.5 times
the normal dose.
Page 6 of 9
MEC Approved: 10/9/2012
Pediatrics Unit Intravenous Push (IVP) Drug List - Approved for RN Administration
Ventura County Medical Center
Generic Name (Brand Names)
LORazepam (Ativan)
Therapeutic Category
Typical Pediatric Dose Maximum
Maximum
Pediatric Dose Concentration
Benzodiazepine 0.05-0.1 mg/kg/dose
Max single dose: 4 1 mg/mL mg
Magnesium Sulfate
Electrolyte HIGH ALERT
25-50 mg/kg/dose
100 mg/kg/dose Max single dose: 2 GM
200 mg/mL
MethylpredniSOLON E Sodium Succinate (Solu-Medrol)
Anti-inflammatory Varies by indication:
Agent:
Asthma:
Corticosteroid 2-4 mg/kg/DAY
Pulse dose:
15-30mg/kg/DAY x 3
days
30 mg/kg/dose
125 mg/mL
Metoclopramide (Reglan)
Antiemetic Prokinetic gastrointestinal agent
0.1-0.2 mg/kg/dose every 6-8 hours
Max single dose: 5 mg/mL 10 mg
Maximum rate of Administration Administration Considerations
0.05 mg/kg over 2- Can cause
5 minutes, not to infiltration with
not exceed 2
IVP.
mg/min.
Slow IVP over at IV PUSH FOR
least 5 minutes in EMERGENCY
emergencies only. USE ONLY.
IV infusion over 2-
4 hours.
Adverse Effects/ Monitoring Parameters Sedation, hypotension, dizziness, headache, HR, RR
Hypotension, CNS depression, loss of deep tendon reflexes, heart block.
Dose 15 mg/kg, Rapid
infuse over 30 administration of
minutes
doses 15 mg/kg
can cause cardiac
arrhythmias &
IVP over >2
cardiac arrest. Too rapid rate may Hypotension, sedation,
minutes.
cause intense
dizziness, rash,
If dose is >10mg, anxiety and/or dystonias & other
give IVPB over 15- drowsiness.
extrapyramidal effects.
30 minutes.
Medication usually Black Box Warning:
placed in the line, tardive dyskinesia
but may be pushed.
Page 7 of 9
MEC Approved: 10/9/2012
Generic Name (Brand Names)
MIDazolam (Versed)
Pediatrics Unit Intravenous Push (IVP) Drug List - Approved for RN Administration
Ventura County Medical Center
Therapeutic Category
Typical Pediatric Dose Maximum Pediatric Dose
Benzodiazepine 0.05-0.1 mg/kg
None
Maximum Concentration
5 mg/mL
Maximum rate of Administration Administration Considerations
Give over 2-5 Reversal agentmins, not to exceed Flumazenil 1 mg/min
Adverse Effects/ Monitoring Parameters Respiratory depression, hypotension, drowsiness. Black Box Warning: respiratory depression.
Morphine Sulfate
Opioid Analgesic 0.05-0.1 mg/kg HIGH ALERT
None
5 mg/mL
Give over >5 minutes.
Reversal agent- Sedation, dizziness, Naloxone (Narcan) heart palpitations,
hypotension, bradycardia, respiratory depression. Black Box Warning: risk of respiratory depression, drug interactions with other CNS depressants, abuse and medication errors.
Naloxone (Narcan)
Antidote:
For full reversal:
N/A
Opioid antagonist ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- highlights of prescribing information narcan nasal spray safely and
- ismp safe practice guidelines for adult iv push medications
- how and when to use naloxone for an opioid overdose cdc
- pediatrics unit intravenous push ivp drug list approved for rn
- pediatric iv push quick ed reference table
- sample protocol to administer naloxone minnesota
- intravenous medication guidelines for adults vchca
- naloxone procedures and protocol for reversal of opioid overdose
- use of naloxone narcan oklahoma
- naloxone frequently asked questions ncdhhs
Related searches
- prescription drug list a z
- drug list alphabetical
- aarp rx drug list and prices
- top 200 drug list 2019
- my drug list medicare
- medicare formulary drug list 2019
- medicare preferred drug list 2019
- medicare part d formulary drug list 2019
- medicare approved drug list 2019
- silverscript drug list 2019
- medicaid drug list 2019
- 200 drug list printables pdf